

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.21721436 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.75333144 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.75333144 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.04782459 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.95547543 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.72594530 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 4.64768960 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.53002526 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.45782038 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.45782038 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.45782038 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.45782038 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.45782038 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.45782038 |
| 15 | regulation of histone H3-K9 methylation (GO:0051570) | 4.35165437 |
| 16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.34912926 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.21508327 |
| 18 | regulation of DNA methylation (GO:0044030) | 4.10086853 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.01523136 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.95048744 |
| 21 | positive regulation of humoral immune response (GO:0002922) | 3.94399467 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 3.93603302 |
| 23 | respiratory burst (GO:0045730) | 3.84895858 |
| 24 | regulation of female gonad development (GO:2000194) | 3.81420679 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.78405817 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.76707045 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.76707045 |
| 28 | mast cell activation (GO:0045576) | 3.75170417 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.73094984 |
| 30 | response to protozoan (GO:0001562) | 3.68879075 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.67110030 |
| 32 | defense response to protozoan (GO:0042832) | 3.66664202 |
| 33 | neutrophil activation (GO:0042119) | 3.62979652 |
| 34 | cellular extravasation (GO:0045123) | 3.55701872 |
| 35 | leukocyte aggregation (GO:0070486) | 3.54610026 |
| 36 | T cell migration (GO:0072678) | 3.48541777 |
| 37 | granulocyte activation (GO:0036230) | 3.44513608 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 3.43548767 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.34498138 |
| 40 | response to muramyl dipeptide (GO:0032495) | 3.26761713 |
| 41 | positive regulation of isotype switching (GO:0045830) | 3.26133349 |
| 42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25971696 |
| 43 | cellular response to arsenic-containing substance (GO:0071243) | 3.23719485 |
| 44 | positive regulation of interferon-alpha production (GO:0032727) | 3.21108199 |
| 45 | myeloid dendritic cell activation (GO:0001773) | 3.20916399 |
| 46 | tolerance induction (GO:0002507) | 3.20485368 |
| 47 | natural killer cell differentiation (GO:0001779) | 3.15856111 |
| 48 | mast cell activation involved in immune response (GO:0002279) | 3.12805596 |
| 49 | mast cell degranulation (GO:0043303) | 3.12805596 |
| 50 | myeloid dendritic cell differentiation (GO:0043011) | 3.12663565 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12116428 |
| 52 | regulation of interferon-alpha production (GO:0032647) | 3.11771795 |
| 53 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.09934916 |
| 54 | response to type I interferon (GO:0034340) | 3.09037369 |
| 55 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.06581240 |
| 56 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.06581240 |
| 57 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.06581240 |
| 58 | negative regulation of phagocytosis (GO:0050765) | 3.05906961 |
| 59 | T cell homeostasis (GO:0043029) | 3.05606918 |
| 60 | response to interleukin-15 (GO:0070672) | 3.05537997 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.04612452 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.04612452 |
| 63 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.04178098 |
| 64 | response to host immune response (GO:0052572) | 3.03929154 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.03929154 |
| 66 | B cell mediated immunity (GO:0019724) | 3.03850328 |
| 67 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.02769558 |
| 68 | protein localization to chromosome, centromeric region (GO:0071459) | 3.02067292 |
| 69 | interferon-gamma production (GO:0032609) | 3.00829979 |
| 70 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.99751321 |
| 71 | positive regulation of B cell mediated immunity (GO:0002714) | 2.96571466 |
| 72 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.96571466 |
| 73 | response to host (GO:0075136) | 2.96333762 |
| 74 | response to host defenses (GO:0052200) | 2.96333762 |
| 75 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96333762 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 2.94529507 |
| 77 | negative regulation of histone methylation (GO:0031061) | 2.94090471 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 2.93157294 |
| 79 | regulation of hypersensitivity (GO:0002883) | 2.92368092 |
| 80 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.91011810 |
| 81 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.90907273 |
| 82 | positive thymic T cell selection (GO:0045059) | 2.89808348 |
| 83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.89158710 |
| 84 | response to peptidoglycan (GO:0032494) | 2.86285122 |
| 85 | mature B cell differentiation (GO:0002335) | 2.85481518 |
| 86 | negative T cell selection (GO:0043383) | 2.85071342 |
| 87 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.84747390 |
| 88 | negative thymic T cell selection (GO:0045060) | 2.84280604 |
| 89 | leukocyte degranulation (GO:0043299) | 2.82108951 |
| 90 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.81643802 |
| 91 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81524160 |
| 92 | regulation of meiosis I (GO:0060631) | 2.80602655 |
| 93 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.79479950 |
| 94 | myeloid leukocyte activation (GO:0002274) | 2.79008944 |
| 95 | lymphocyte homeostasis (GO:0002260) | 2.77962185 |
| 96 | hepatocyte apoptotic process (GO:0097284) | 2.77652778 |
| 97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.77509050 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 2.75175045 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74783810 |
| 100 | pinocytosis (GO:0006907) | 2.74242286 |
| 101 | T-helper 1 type immune response (GO:0042088) | 2.74135790 |
| 102 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.72577952 |
| 103 | positive regulation of interleukin-2 production (GO:0032743) | 2.72354285 |
| 104 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.72085585 |
| 105 | establishment of chromosome localization (GO:0051303) | 2.70124944 |
| 106 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.69293725 |
| 107 | meiotic cell cycle (GO:0051321) | 2.66639929 |
| 108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.65422914 |
| 109 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64822037 |
| 110 | mature B cell differentiation involved in immune response (GO:0002313) | 2.63984212 |
| 111 | mitotic chromosome condensation (GO:0007076) | 2.63646374 |
| 112 | natural killer cell activation (GO:0030101) | 2.63390154 |
| 113 | positive regulation of DNA recombination (GO:0045911) | 2.63177135 |
| 114 | protein kinase C signaling (GO:0070528) | 2.62703322 |
| 115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.62687667 |
| 116 | positive regulation of interferon-beta production (GO:0032728) | 2.62370874 |
| 117 | positive regulation of chromosome segregation (GO:0051984) | 2.61770468 |
| 118 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61291751 |
| 119 | negative regulation of interleukin-17 production (GO:0032700) | 2.61263167 |
| 120 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.61235657 |
| 121 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.60159634 |
| 122 | cellular response to interleukin-15 (GO:0071350) | 2.59357538 |
| 123 | dendritic cell differentiation (GO:0097028) | 2.58500122 |
| 124 | protein localization to kinetochore (GO:0034501) | 2.58461534 |
| 125 | detection of other organism (GO:0098543) | 2.58341199 |
| 126 | positive regulation of immunoglobulin production (GO:0002639) | 2.58076217 |
| 127 | viral transcription (GO:0019083) | 2.57811738 |
| 128 | germinal center formation (GO:0002467) | 2.57450575 |
| 129 | positive regulation of B cell activation (GO:0050871) | 2.57044073 |
| 130 | detection of bacterium (GO:0016045) | 2.51831346 |
| 131 | mitotic metaphase plate congression (GO:0007080) | 2.44557777 |
| 132 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.43188972 |
| 133 | B cell proliferation (GO:0042100) | 2.42969650 |
| 134 | regulation of chromatin silencing (GO:0031935) | 2.40645666 |
| 135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.40325993 |
| 136 | B cell homeostasis (GO:0001782) | 2.38404673 |
| 137 | oocyte development (GO:0048599) | 2.38131988 |
| 138 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.37700088 |
| 139 | T cell lineage commitment (GO:0002360) | 2.37619203 |
| 140 | positive regulation of B cell proliferation (GO:0030890) | 2.36824977 |
| 141 | piRNA metabolic process (GO:0034587) | 2.35411242 |
| 142 | regulation of vitamin metabolic process (GO:0030656) | 2.34014338 |
| 143 | regulation of interleukin-12 production (GO:0032655) | 2.33986648 |
| 144 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.32201297 |
| 145 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.31892857 |
| 146 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.29965952 |
| 147 | positive regulation of interleukin-10 production (GO:0032733) | 2.29759263 |
| 148 | regulation of interferon-beta production (GO:0032648) | 2.29627567 |
| 149 | female gamete generation (GO:0007292) | 2.28527427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.59419397 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52499844 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.23747798 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.81152415 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.63694120 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.59116220 |
| 7 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.55213421 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.34273396 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.29039697 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.18987072 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.04411313 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.95367620 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.93405710 |
| 14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92796609 |
| 15 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.86182851 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80893268 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.78853512 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78827337 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.72978174 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70140136 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.50523308 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.50067673 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.49305575 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.37204396 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.36634359 |
| 26 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.35837427 |
| 27 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.35837427 |
| 28 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.35837427 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.33317809 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.28539524 |
| 31 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27806265 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.26884630 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21689769 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20836786 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.17806811 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14136468 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.12678637 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 2.09461992 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04919414 |
| 40 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99680527 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.92593225 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92585143 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87594580 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84839717 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75885289 |
| 46 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.69446475 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67983723 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66832874 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.65047660 |
| 50 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.63102711 |
| 51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.60890992 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60569799 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59793331 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56477687 |
| 55 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53721580 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52059687 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49718065 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.47442068 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46949482 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44526100 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43819105 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43571273 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41597949 |
| 64 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.40673342 |
| 65 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40316075 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40011289 |
| 67 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38446691 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37290103 |
| 69 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36867665 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.35600039 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32763837 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27850054 |
| 73 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.24664421 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23494273 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23179600 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20396275 |
| 77 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19192115 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16050499 |
| 79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15215261 |
| 80 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14222331 |
| 81 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13563450 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11551500 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11483657 |
| 84 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.10778308 |
| 85 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.09666757 |
| 86 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08951143 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08007392 |
| 88 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06775990 |
| 89 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04501979 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02956907 |
| 91 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.01960199 |
| 92 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00514218 |
| 93 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.99535421 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99011606 |
| 95 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98876554 |
| 96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97172209 |
| 97 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94507021 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94323926 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93609214 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93562327 |
| 101 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93065469 |
| 102 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.89415314 |
| 103 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.88787192 |
| 104 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87729320 |
| 105 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86052550 |
| 106 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85602522 |
| 107 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85277071 |
| 108 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82840476 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81612974 |
| 110 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.81449959 |
| 111 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.80992885 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80759206 |
| 113 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.80083787 |
| 114 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.80071384 |
| 115 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78764215 |
| 116 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78724565 |
| 117 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78616959 |
| 118 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.77904918 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77100730 |
| 120 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.76577659 |
| 121 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.76472462 |
| 122 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.76369344 |
| 123 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74895810 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73695175 |
| 125 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73422607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.89886661 |
| 2 | MP0003303_peritoneal_inflammation | 3.39341380 |
| 3 | MP0003436_decreased_susceptibility_to | 3.30442803 |
| 4 | MP0000685_abnormal_immune_system | 3.17868092 |
| 5 | MP0009785_altered_susceptibility_to | 3.10229839 |
| 6 | MP0001800_abnormal_humoral_immune | 3.06728804 |
| 7 | MP0003718_maternal_effect | 3.06662670 |
| 8 | MP0005671_abnormal_response_to | 2.93497438 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.91890358 |
| 10 | MP0005387_immune_system_phenotype | 2.91083330 |
| 11 | MP0001790_abnormal_immune_system | 2.91083330 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.74964690 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.67206076 |
| 14 | * MP0002723_abnormal_immune_serum | 2.62941801 |
| 15 | MP0005025_abnormal_response_to | 2.60421509 |
| 16 | * MP0002419_abnormal_innate_immunity | 2.59838539 |
| 17 | * MP0002420_abnormal_adaptive_immunity | 2.54151897 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.53860277 |
| 19 | * MP0001819_abnormal_immune_cell | 2.51153826 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.48206822 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.46646511 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.43231782 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.36723047 |
| 24 | * MP0002398_abnormal_bone_marrow | 2.36239942 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.31918187 |
| 26 | MP0003724_increased_susceptibility_to | 2.31836171 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.22964307 |
| 28 | MP0002405_respiratory_system_inflammati | 2.19231447 |
| 29 | * MP0000716_abnormal_immune_system | 2.14968519 |
| 30 | MP0006082_CNS_inflammation | 2.13603343 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 2.12237247 |
| 32 | MP0001545_abnormal_hematopoietic_system | 2.12237247 |
| 33 | MP0009278_abnormal_bone_marrow | 2.09814822 |
| 34 | MP0000689_abnormal_spleen_morphology | 2.05441123 |
| 35 | MP0010155_abnormal_intestine_physiology | 2.03909188 |
| 36 | MP0001873_stomach_inflammation | 1.97932390 |
| 37 | MP0002722_abnormal_immune_system | 1.95680026 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.95057249 |
| 39 | MP0001853_heart_inflammation | 1.92725956 |
| 40 | MP0004947_skin_inflammation | 1.92153559 |
| 41 | MP0002006_tumorigenesis | 1.91836423 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.88105393 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.85015788 |
| 44 | * MP0002429_abnormal_blood_cell | 1.84647505 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.83992273 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.82224934 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.67077042 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.63980389 |
| 49 | MP0003866_abnormal_defecation | 1.56756826 |
| 50 | MP0004510_myositis | 1.55696494 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.54800517 |
| 52 | MP0002933_joint_inflammation | 1.54520219 |
| 53 | MP0005451_abnormal_body_composition | 1.45604894 |
| 54 | MP0005310_abnormal_salivary_gland | 1.44402456 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.38075291 |
| 56 | MP0008469_abnormal_protein_level | 1.34851791 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.33862428 |
| 58 | MP0003111_abnormal_nucleus_morphology | 1.32115420 |
| 59 | MP0000858_altered_metastatic_potential | 1.27983548 |
| 60 | MP0000490_abnormal_crypts_of | 1.26262100 |
| 61 | MP0009764_decreased_sensitivity_to | 1.22534023 |
| 62 | MP0003448_altered_tumor_morphology | 1.21814122 |
| 63 | MP0001851_eye_inflammation | 1.17422892 |
| 64 | MP0005395_other_phenotype | 1.17237552 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.16516563 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.13363161 |
| 67 | MP0004957_abnormal_blastocyst_morpholog | 1.09619774 |
| 68 | MP0008004_abnormal_stomach_pH | 1.09217221 |
| 69 | MP0003890_abnormal_embryonic-extraembry | 1.05809624 |
| 70 | MP0009840_abnormal_foam_cell | 1.05256383 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 1.04936681 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.04879986 |
| 73 | MP0010307_abnormal_tumor_latency | 1.03977495 |
| 74 | MP0000350_abnormal_cell_proliferation | 1.03864748 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.02919925 |
| 76 | MP0005166_decreased_susceptibility_to | 1.02710824 |
| 77 | MP0003191_abnormal_cellular_cholesterol | 1.02111788 |
| 78 | MP0003075_altered_response_to | 1.02021230 |
| 79 | MP0005647_abnormal_sex_gland | 1.00757205 |
| 80 | MP0000343_altered_response_to | 0.97882445 |
| 81 | MP0005023_abnormal_wound_healing | 0.97042359 |
| 82 | MP0001730_embryonic_growth_arrest | 0.96437582 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.96356473 |
| 84 | MP0003699_abnormal_female_reproductive | 0.95655953 |
| 85 | MP0001663_abnormal_digestive_system | 0.93308784 |
| 86 | MP0006054_spinal_hemorrhage | 0.91910617 |
| 87 | MP0008058_abnormal_DNA_repair | 0.91552121 |
| 88 | MP0002796_impaired_skin_barrier | 0.90875452 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.90440090 |
| 90 | MP0008057_abnormal_DNA_replication | 0.88396316 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.87720322 |
| 92 | MP0002132_abnormal_respiratory_system | 0.86551824 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.86357571 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.83575521 |
| 95 | MP0003828_pulmonary_edema | 0.83570660 |
| 96 | MP0005410_abnormal_fertilization | 0.81853581 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.79521481 |
| 98 | MP0000249_abnormal_blood_vessel | 0.79336916 |
| 99 | MP0009763_increased_sensitivity_to | 0.76274609 |
| 100 | MP0000604_amyloidosis | 0.75893885 |
| 101 | MP0008260_abnormal_autophagy | 0.73855941 |
| 102 | MP0010678_abnormal_skin_adnexa | 0.73797453 |
| 103 | MP0004264_abnormal_extraembryonic_tissu | 0.72968712 |
| 104 | MP0001881_abnormal_mammary_gland | 0.72723961 |
| 105 | MP0003693_abnormal_embryo_hatching | 0.71679892 |
| 106 | MP0008873_increased_physiological_sensi | 0.70439535 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.69961517 |
| 108 | MP0008007_abnormal_cellular_replicative | 0.69342664 |
| 109 | MP0003252_abnormal_bile_duct | 0.69246939 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.66250729 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.65840608 |
| 112 | MP0005390_skeleton_phenotype | 0.64880522 |
| 113 | MP0002254_reproductive_system_inflammat | 0.63992057 |
| 114 | MP0010094_abnormal_chromosome_stability | 0.62463552 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.60861137 |
| 116 | MP0003091_abnormal_cell_migration | 0.60447101 |
| 117 | MP0005164_abnormal_response_to | 0.59833549 |
| 118 | MP0003077_abnormal_cell_cycle | 0.59687913 |
| 119 | MP0000313_abnormal_cell_death | 0.59238296 |
| 120 | MP0003795_abnormal_bone_structure | 0.57750034 |
| 121 | MP0001915_intracranial_hemorrhage | 0.57507767 |
| 122 | MP0009931_abnormal_skin_appearance | 0.54664427 |
| 123 | MP0001879_abnormal_lymphatic_vessel | 0.53953317 |
| 124 | MP0005621_abnormal_cell_physiology | 0.52828145 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.51918321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.69720007 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.34803475 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.97722378 |
| 4 | Cellulitis (HP:0100658) | 4.64930711 |
| 5 | Recurrent viral infections (HP:0004429) | 4.57469018 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.48623086 |
| 7 | Chronic otitis media (HP:0000389) | 4.27719581 |
| 8 | Stomatitis (HP:0010280) | 4.23060376 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.08270442 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.96276249 |
| 11 | B lymphocytopenia (HP:0010976) | 3.91200215 |
| 12 | Abnormality of B cell number (HP:0010975) | 3.91200215 |
| 13 | Meningitis (HP:0001287) | 3.80532803 |
| 14 | Agammaglobulinemia (HP:0004432) | 3.79712578 |
| 15 | Myositis (HP:0100614) | 3.73885291 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.63663414 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.61319009 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.56713946 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.55548394 |
| 20 | Obstructive lung disease (HP:0006536) | 3.55241265 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.55241265 |
| 22 | Thyroiditis (HP:0100646) | 3.54818379 |
| 23 | IgM deficiency (HP:0002850) | 3.53463476 |
| 24 | T lymphocytopenia (HP:0005403) | 3.51190353 |
| 25 | Recurrent skin infections (HP:0001581) | 3.49927853 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.39897617 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.35966612 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.35966612 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.35966612 |
| 30 | Thrombocytosis (HP:0001894) | 3.33516334 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 3.30430137 |
| 32 | Inflammation of the large intestine (HP:0002037) | 3.24206142 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 3.23403356 |
| 34 | Vasculitis (HP:0002633) | 3.23018593 |
| 35 | Osteomyelitis (HP:0002754) | 3.18976762 |
| 36 | Gastrointestinal inflammation (HP:0004386) | 3.17180796 |
| 37 | Pustule (HP:0200039) | 3.14663563 |
| 38 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.10615153 |
| 39 | Prolonged bleeding time (HP:0003010) | 3.10121334 |
| 40 | Papilloma (HP:0012740) | 3.05836305 |
| 41 | Verrucae (HP:0200043) | 3.05836305 |
| 42 | Combined immunodeficiency (HP:0005387) | 3.04707411 |
| 43 | Loss of speech (HP:0002371) | 3.04308650 |
| 44 | Petechiae (HP:0000967) | 2.98168128 |
| 45 | Abnormality of T cells (HP:0002843) | 2.88310546 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.85458706 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.85458706 |
| 48 | Leukocytosis (HP:0001974) | 2.80973927 |
| 49 | Colitis (HP:0002583) | 2.80432110 |
| 50 | Gingivitis (HP:0000230) | 2.76971724 |
| 51 | Prostate neoplasm (HP:0100787) | 2.75284029 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.75165701 |
| 53 | Epistaxis (HP:0000421) | 2.73969105 |
| 54 | Sepsis (HP:0100806) | 2.73362225 |
| 55 | Increased IgM level (HP:0003496) | 2.71229801 |
| 56 | Eosinophilia (HP:0001880) | 2.70498545 |
| 57 | Orchitis (HP:0100796) | 2.68777293 |
| 58 | Optic neuritis (HP:0100653) | 2.67876565 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.67876565 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.63450582 |
| 61 | Premature loss of primary teeth (HP:0006323) | 2.63427661 |
| 62 | Nasal polyposis (HP:0100582) | 2.63378756 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.60229264 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.58911671 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 2.58581636 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.54254141 |
| 67 | Cholecystitis (HP:0001082) | 2.53884454 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 2.53884454 |
| 69 | Lymphopenia (HP:0001888) | 2.52190950 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.51208191 |
| 71 | IgG deficiency (HP:0004315) | 2.49537419 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.48995019 |
| 73 | Granulocytopenia (HP:0001913) | 2.44800367 |
| 74 | Pulmonary infiltrates (HP:0002113) | 2.44686243 |
| 75 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44684937 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.42671060 |
| 77 | Gingival bleeding (HP:0000225) | 2.41639863 |
| 78 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.40693866 |
| 79 | Abnormality of the nasal mucosa (HP:0000433) | 2.40371998 |
| 80 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.38928534 |
| 81 | Arterial thrombosis (HP:0004420) | 2.36607148 |
| 82 | Diminished motivation (HP:0000745) | 2.35841875 |
| 83 | Periodontitis (HP:0000704) | 2.35280739 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 2.34944407 |
| 85 | Anhidrosis (HP:0000970) | 2.34905050 |
| 86 | Lymphoma (HP:0002665) | 2.33772882 |
| 87 | Apathy (HP:0000741) | 2.31949094 |
| 88 | Chronic sinusitis (HP:0011109) | 2.31826520 |
| 89 | Skin ulcer (HP:0200042) | 2.28656738 |
| 90 | Chest pain (HP:0100749) | 2.27265058 |
| 91 | Abnormal number of erythroid precursors (HP:0012131) | 2.26372901 |
| 92 | Increased IgE level (HP:0003212) | 2.25717256 |
| 93 | Supernumerary spleens (HP:0009799) | 2.25316107 |
| 94 | Hemoptysis (HP:0002105) | 2.24644293 |
| 95 | Acute lymphatic leukemia (HP:0006721) | 2.22346377 |
| 96 | Abnormality of the prostate (HP:0008775) | 2.21173401 |
| 97 | Viral hepatitis (HP:0006562) | 2.18303319 |
| 98 | Emphysema (HP:0002097) | 2.17969745 |
| 99 | Multiple enchondromatosis (HP:0005701) | 2.17397618 |
| 100 | Hematochezia (HP:0002573) | 2.15671701 |
| 101 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14986660 |
| 102 | Pulmonary fibrosis (HP:0002206) | 2.12717562 |
| 103 | Intrahepatic cholestasis (HP:0001406) | 2.10538766 |
| 104 | Fatigue (HP:0012378) | 2.08297950 |
| 105 | Xerostomia (HP:0000217) | 2.07048986 |
| 106 | Facial hemangioma (HP:0000329) | 2.06451057 |
| 107 | Abnormal platelet function (HP:0011869) | 2.06381259 |
| 108 | Impaired platelet aggregation (HP:0003540) | 2.06381259 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 2.05110501 |
| 110 | Abnormality of the fingertips (HP:0001211) | 2.05008768 |
| 111 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03258001 |
| 112 | Urticaria (HP:0001025) | 2.03144026 |
| 113 | IgA deficiency (HP:0002720) | 2.02592892 |
| 114 | Premature ovarian failure (HP:0008209) | 2.02377832 |
| 115 | Chromsome breakage (HP:0040012) | 2.02278344 |
| 116 | Gastrointestinal infarctions (HP:0005244) | 2.00883864 |
| 117 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.00024194 |
| 118 | Conjunctival telangiectasia (HP:0000524) | 1.98618778 |
| 119 | Recurrent sinusitis (HP:0011108) | 1.98209436 |
| 120 | Hepatosplenomegaly (HP:0001433) | 1.98018587 |
| 121 | Encephalitis (HP:0002383) | 1.95937549 |
| 122 | Restrictive lung disease (HP:0002091) | 1.95362797 |
| 123 | Papillary thyroid carcinoma (HP:0002895) | 1.94981020 |
| 124 | Keratoconjunctivitis sicca (HP:0001097) | 1.94850831 |
| 125 | Increased serum ferritin (HP:0003281) | 1.94638313 |
| 126 | Increased cerebral lipofuscin (HP:0011813) | 1.93757562 |
| 127 | Skin rash (HP:0000988) | 1.93194654 |
| 128 | Amaurosis fugax (HP:0100576) | 1.92236489 |
| 129 | Metaphyseal irregularity (HP:0003025) | 1.92222935 |
| 130 | Chronic diarrhea (HP:0002028) | 1.91781732 |
| 131 | Disinhibition (HP:0000734) | 1.91349577 |
| 132 | Lower limb hyperreflexia (HP:0002395) | 1.89421307 |
| 133 | Malnutrition (HP:0004395) | 1.88325732 |
| 134 | Neutropenia (HP:0001875) | 1.88116657 |
| 135 | Agnosia (HP:0010524) | 1.85615604 |
| 136 | Aplastic anemia (HP:0001915) | 1.83936095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.55838248 |
| 2 | RIPK4 | 3.28235022 |
| 3 | PRPF4B | 3.21710889 |
| 4 | MAP3K10 | 2.90499284 |
| 5 | EIF2AK3 | 2.82384169 |
| 6 | ARAF | 2.77782086 |
| 7 | EEF2K | 2.71678419 |
| 8 | MAP3K14 | 2.66255991 |
| 9 | TBK1 | 2.51019485 |
| 10 | JAK3 | 2.50669237 |
| 11 | TXK | 2.49928055 |
| 12 | TYK2 | 2.28154759 |
| 13 | MAP3K9 | 2.25760369 |
| 14 | IKBKE | 2.21504419 |
| 15 | BTK | 2.09583146 |
| 16 | GRK6 | 2.08868739 |
| 17 | ZAP70 | 2.07518642 |
| 18 | BLK | 2.03097570 |
| 19 | STK10 | 2.03040622 |
| 20 | KIT | 2.00830654 |
| 21 | TEC | 2.00069596 |
| 22 | NEK9 | 1.90406415 |
| 23 | ERN1 | 1.82018360 |
| 24 | ITK | 1.79802667 |
| 25 | SYK | 1.79612625 |
| 26 | IKBKB | 1.75840906 |
| 27 | PIM2 | 1.70612922 |
| 28 | MAP3K13 | 1.64808995 |
| 29 | MOS | 1.61440273 |
| 30 | PIM1 | 1.60220942 |
| 31 | FES | 1.59342411 |
| 32 | IRAK4 | 1.55040893 |
| 33 | MST4 | 1.54553287 |
| 34 | TAOK2 | 1.48535093 |
| 35 | JAK1 | 1.45059390 |
| 36 | HCK | 1.44966244 |
| 37 | LRRK2 | 1.42435578 |
| 38 | PBK | 1.39529334 |
| 39 | LCK | 1.37073133 |
| 40 | KDR | 1.35899356 |
| 41 | NME2 | 1.34130234 |
| 42 | EPHB1 | 1.32488304 |
| 43 | CSK | 1.31953834 |
| 44 | RPS6KB2 | 1.31565508 |
| 45 | MAP2K3 | 1.24975642 |
| 46 | CSF1R | 1.23090259 |
| 47 | RPS6KA4 | 1.22397683 |
| 48 | NEK6 | 1.21388024 |
| 49 | TGFBR2 | 1.18716408 |
| 50 | LYN | 1.18272294 |
| 51 | TTK | 1.18221692 |
| 52 | SIK2 | 1.17286998 |
| 53 | CDC7 | 1.16667640 |
| 54 | MAP3K11 | 1.15739867 |
| 55 | BRAF | 1.14296488 |
| 56 | PKN2 | 1.08894314 |
| 57 | MATK | 1.04306844 |
| 58 | STK4 | 1.03251266 |
| 59 | CLK1 | 1.02725401 |
| 60 | BRD4 | 1.02645969 |
| 61 | TAOK3 | 1.01240549 |
| 62 | FLT3 | 0.97274557 |
| 63 | SCYL2 | 0.96731173 |
| 64 | TESK2 | 0.96547421 |
| 65 | CHUK | 0.93222180 |
| 66 | TRIB3 | 0.92555507 |
| 67 | JAK2 | 0.92213340 |
| 68 | NLK | 0.91485958 |
| 69 | EIF2AK2 | 0.84393688 |
| 70 | SMG1 | 0.82670622 |
| 71 | AURKA | 0.81970685 |
| 72 | FGFR4 | 0.81643610 |
| 73 | RAF1 | 0.80625869 |
| 74 | CDK4 | 0.78532222 |
| 75 | GRK7 | 0.77653166 |
| 76 | TRPM7 | 0.76525655 |
| 77 | KSR2 | 0.75656298 |
| 78 | MARK3 | 0.75424394 |
| 79 | IRAK3 | 0.73234551 |
| 80 | MAP3K7 | 0.73083638 |
| 81 | CDK7 | 0.66710665 |
| 82 | PRKCI | 0.66006133 |
| 83 | TIE1 | 0.65968759 |
| 84 | RIPK1 | 0.65350803 |
| 85 | MAP3K3 | 0.65271190 |
| 86 | MAP3K12 | 0.62341024 |
| 87 | MAPK4 | 0.61797103 |
| 88 | MAPKAPK3 | 0.61361685 |
| 89 | FGFR3 | 0.61290066 |
| 90 | HIPK2 | 0.58590303 |
| 91 | ZAK | 0.57048348 |
| 92 | NEK2 | 0.56982745 |
| 93 | STK24 | 0.56160393 |
| 94 | CDK12 | 0.56005695 |
| 95 | FGR | 0.55625665 |
| 96 | ACVR1B | 0.52910685 |
| 97 | SIK3 | 0.50410686 |
| 98 | VRK1 | 0.49940330 |
| 99 | ABL1 | 0.48526841 |
| 100 | PRKCQ | 0.48083392 |
| 101 | TAOK1 | 0.47401791 |
| 102 | MAP3K1 | 0.47383895 |
| 103 | MAP3K8 | 0.46731961 |
| 104 | CDK6 | 0.45888737 |
| 105 | MAPKAPK2 | 0.45671658 |
| 106 | MAPKAPK5 | 0.44277370 |
| 107 | IRAK1 | 0.43542206 |
| 108 | PTK6 | 0.42872595 |
| 109 | PRKG2 | 0.41837978 |
| 110 | EGFR | 0.39042529 |
| 111 | CHEK1 | 0.38504921 |
| 112 | MARK2 | 0.37616306 |
| 113 | MAP3K5 | 0.36816168 |
| 114 | PIK3CG | 0.36796036 |
| 115 | STK3 | 0.36551400 |
| 116 | RPS6KA5 | 0.36033056 |
| 117 | TNK2 | 0.35596479 |
| 118 | RPS6KA6 | 0.34115056 |
| 119 | PDK1 | 0.33680151 |
| 120 | PLK1 | 0.33582699 |
| 121 | BMPR2 | 0.33432795 |
| 122 | MAPK11 | 0.32926458 |
| 123 | PRKCD | 0.32195477 |
| 124 | MKNK1 | 0.31476709 |
| 125 | PLK4 | 0.31398989 |
| 126 | MAPK3 | 0.29157809 |
| 127 | MELK | 0.28043709 |
| 128 | FYN | 0.25044283 |
| 129 | CDK9 | 0.23256219 |
| 130 | TGFBR1 | 0.21390873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.49263894 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04289527 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.83251771 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67501390 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49732793 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32467383 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.20991014 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.11873428 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.11076866 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10635860 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.10569206 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.06662970 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.97132696 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96767140 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.92413153 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.84247769 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69468156 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68946140 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67433577 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63961751 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.63534428 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63120741 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.62908841 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58776360 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.57963959 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.56933478 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56832746 |
| 28 | Cell cycle_Homo sapiens_hsa04110 | 1.54360935 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.51356428 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50136431 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49244791 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48122714 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44522234 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44251246 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.42820064 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.41465150 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.40684594 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36223911 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.32744914 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26556271 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.25253199 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16449106 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.15059855 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13296767 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12200176 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10948037 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.09231237 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04992509 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04265494 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.02275076 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00125950 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96609512 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.96257919 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95788288 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93911371 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92465688 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91903591 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 0.90566305 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88391103 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86797086 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80447891 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80344906 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79803044 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.79143884 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 0.79078650 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78760228 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75512231 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75106211 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74137531 |
| 70 | DNA replication_Homo sapiens_hsa03030 | 0.74003225 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73857381 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72843872 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71549423 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69610797 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.65651760 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.65552229 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63879987 |
| 78 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.63416170 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62897443 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61569316 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.61389479 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60176961 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57403032 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56258743 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55166677 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.53175812 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.53040218 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51937153 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.51373707 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50982686 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.50303357 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49796798 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46055861 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45150355 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43964020 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43737570 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43343170 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43315266 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43127936 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41220226 |
| 101 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39373873 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36778373 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35395348 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33815680 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33158534 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30363644 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29920609 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29522640 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29012511 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.28015119 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27874241 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.27273833 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25012095 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.24761137 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24685094 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23072754 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22795252 |
| 118 | Mismatch repair_Homo sapiens_hsa03430 | 0.22327314 |
| 119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22040884 |

